David H. Harpole, Jr., M.D.
David H. Harpole, Jr., M.D.
Associate Professor of Surgery with Tenure Assistant Professor of Pathology
|EDUCATION INSTITUTION||DEGREE||YEAR(s)||FIELD OF STUDY|
|Washington & Lee University Lexington, VA
University of Virginia Charlottesville, VA
Fuqua School of Business, Duke University Durham, NC
Physician Executive Leadership Program
Research and Professional Experience
|Duke University Medical Center||Harvard Medical School|
|1984-1985 Intern in General Surgery||1993-1996 Instructor in Surgery|
|1985-1986 Junior Assistant Surgical Resident||1993-1996 Brigham and Women's Hospital Associate in Thoracic Surgery|
|1986-1988 Thoracic Surgical Research Fellow||1993-1996 Dana Farber Cancer Institute Consultant in Thoracic Surgery|
|1988-1991 Senior Assistant Surgical Resident||1993-1996 West Roxbury VA Medical Center Staff Thoracic Surgeon|
|1991-1992 Chief Resident in General Surgery||Durham Veterans Affair Medical Center|
|1992-1993 Teaching Scholar in Thoracic Surgery||1996-present Chief, Cardiothoracic Surgery|
|1996-present Director, Lung Cancer Prognostic Research Laboratory|
|1996-present Associate Professor of Surgery, Thoracic Oncology Program|
|Honors and Awards|
|1979 Phi Beta kappa, Alpha Epsilon Delta, Omicron Delta Kappa|
|1980 Summa Cum laude graduate of Washington & Lee University|
|1982 Outstanding Young Men of America|
|1984 Raven Honorary Society of the University of Virginia|
|1986-1988 Raymond W. Postlehwait Fellow in Surgical Research|
|1993 American Board of Surgery No. 38463|
|1994 American Board of Thoracic Surgery No. 5468|
|1992 Association for Academic Surgery|
|1994 Society of Surgical Oncology||American Society of Clinical Oncology|
|1996 American College of Surgeons||Fellow, American College of Chest Physicians|
|1997 The Society of Thoracic Surgeons|
|1997 Cadre member Cancer and Leukemia Group B (CALGB)||Thoracic Surgery Subcommittee Chair, CALGB|
|1998 Society of University Surgeons|
|2000 American Association for Thoracic Surgery|
|1976-1980 Robert E. Lee Research Scholar, Washington and Lee University|
|1979 National Science Foundation Research Scholar, University of North Carolina|
|1980-1981 Surgical oncology Research Laboratory, University of Virginia|
|1986-1988 Cardiothoracic Research Fellow, Duke University Medical Center|
|1992-1993 Oncogene Expression in Lung Cancer, Duke University Medical Center|
|1993-1996 Director of the Tissue Bank and Lung Cancer Research Laboratory, Brigham & Women's Hospital|
|1996-present Director of the Tissue and Lung Cancer Prognostic Research Laboratory, Duke University Medical Center|
Harpole DH, Bigelow C, Young WG Jr, Wolfe WG, Sabiston DC Jr. Alveolar cell carcinoma of the lung: a retrospective analysis of 205 patients. Ann Thorac Surg 1988; 46:502-7.
Harpole DH Jr, Herndon JE, Wolfe WG, Iglehart JD, Marks JR. A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression. Cancer Res 1995; 55:51-56
Harpole DH Jr, Kwiatkowski DJ, Strauss GM, Lynch TJ, Skarin AT, Sugarbaker DJ. Molecular and pathologic analysis of stage I non-small cell lung carcinoma of the lung. J Clin Oncol 1995;13:1265-1279.
Harpole DH Jr, Jaklitsch MT, Mentxer SJ, DeCamp, MM Jr, Sugarbaker DJ. The Safety and Versatility of Video-Thoracoscopy: A Prospective Analysis of 895 Consecutive Cases. J Am Coll Surg 1995; 181:113-120
Harpole DH Jr, Healey EA, DeCamp MM Jr, Mentzer SJ, Wormuth DW, Strauss GM, Sugarbaker DJ. Multimodality therapy for chest wall invasive lung cancer: patterns of failure and implications for a revised staging system. Ann Surg Oncol; 1996; 3:261-269.
Harpole DH Jr, Liptay MJ, DeCamp MM Jr, Mentzer SJ, Swanson SJ, Sugarbaker DJ. Prospective analysis of pneumonectomy: risk factors for major morbidity and cardiac dysrhythmias. Ann Thorac Surg 1996; 61:977-982.
Harpole DH, Garcia JP, Sugarbaker DJ, Baldini EH, DeCamp MM, Mentzer SJ, liptay MJ, Strauss GM, Swanson SJ. Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma: results in 120 consecutive patients. Annals of Surgery 1996;224:228-296
Harpole DH, Jr, Massey M, Herndon JE II, Moore MB, D'Amico TA: A Biologic risk model for Stage I lung cancer: Immunohistochemical analysis of 408 patients using 10 molecular markers. J Thorac Cardiovasc Surg 1999;117:736-743.